{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:54:20Z","timestamp":1791298460075,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"DOI":"10.1007\/s43441-026-01059-y","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:37:04Z","timestamp":1791297424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of the EU Clinical Trials Regulation and CTIS in Europe: a Comparative Regulatory Analysis (2013\u20132024)"],"prefix":"10.1007","author":[{"given":"Jose","family":"Seijas-Amigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rodriguez-Penas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Cardeso-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ribeiro-Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Escalante-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s","family":"Rodriguez-Ma\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ramon","family":"Gonzalez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"9","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"e1648","DOI":"10.1016\/S2214-109X(25)00218-9","volume":"13","author":"ES Higgs","year":"2025","unstructured":"Higgs ES, Altaf A, Lurie N, et al. National research ecosystems: protecting populations and building health security worldwide. Lancet Glob Health. 2025;13(9):e1648\u201353. https:\/\/doi.org\/10.1016\/S2214-109X(25)00218-9.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"1059_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2471\/BLT.11.092007","volume":"90","author":"B Pratt","year":"2012","unstructured":"Pratt B, Loff B. Health research systems: promoting health equity or economic competitiveness? Bull World Health Organ. 2012;90(1):55\u201362. https:\/\/doi.org\/10.2471\/BLT.11.092007.","journal-title":"Bull World Health Organ"},{"key":"1059_CR3","unstructured":"IQVIA EFPIA. Assessing the clinical trial ecosystem in Europe. 2024."},{"key":"1059_CR4","unstructured":"World Health Organization. Number of clinical trials by year, country, WHO region and income group (1999\u20132025) [Internet]. Geneva: World Health Organization; 2026 [cited 2026 Oct 5]. Available from: https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-clinical-trials-by-year-country-who-region-and-income-group"},{"issue":"2","key":"1059_CR5","doi-asserted-by":"publisher","first-page":"e0192413","DOI":"10.1371\/journal.pone.0192413","volume":"13","author":"PK Drain","year":"2018","unstructured":"Drain PK, Parker RA, Robine M, Holmes KK, Bassett IV. Global migration of clinical research during the era of trial registration. PLoS ONE. 2018;13(2):e0192413. https:\/\/doi.org\/10.1371\/journal.pone.0192413. Published 2018 Feb 28.","journal-title":"PLoS ONE"},{"key":"1059_CR6","doi-asserted-by":"publisher","DOI":"10.2826\/239658","volume-title":"Advanced technologies for industry \u2013 EU report: technological trends and policies","author":"European Commission","year":"2020","unstructured":"European Commission. Advanced technologies for industry \u2013 EU report: technological trends and policies. Luxembourg: Publications Office of the European Union; 2020. https:\/\/doi.org\/10.2826\/239658."},{"key":"1059_CR7","first-page":"34","volume":"L121","author":"European Parliament, Council of the European Union","year":"2001","unstructured":"European Parliament, Council of the European Union. Directive 2001\/20\/EC on the conduct of clinical trials on medicinal products for human use. Off J Eur Communities. 2001;L121:34\u201344.","journal-title":"Off J Eur Communities"},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1745-6215-13-53","volume":"13","author":"M Hartmann","year":"2012","unstructured":"Hartmann M. Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries. Trials. 2012;13:53. https:\/\/doi.org\/10.1186\/1745-6215-13-53. Published 2012 Apr 29.","journal-title":"Trials"},{"issue":"4","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2125.2008.03246.x","volume":"66","author":"HJ Lambers Heerspink","year":"2008","unstructured":"Lambers Heerspink HJ, Dobre D, Hillege HL, Grobbee DE, de Zeeuw D. Does the European clinical trials directive really improve clinical trial approval time? Br J Clin Pharmacol. 2008;66(4):546\u201350. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03246.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1059_CR10","first-page":"1","volume":"L158","author":"European Parliament, Council of the European Union","year":"2014","unstructured":"European Parliament, Council of the European Union. Regulation (EU) 536\/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001\/20\/EC. Official J Eur Union. 2014;L158:1\u201376.","journal-title":"Official J Eur Union"},{"key":"1059_CR11","unstructured":"European Medicines Agency. Clinical Trials Information System (CTIS). Amsterdam: European Medicines Agency. 2022. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/clinical-trials\/clinical-trials-information-system."},{"key":"1059_CR12","unstructured":"European Commission. Objectives and expected impacts of Regulation (EU) No 536\/2014 on clinical trials on medicinal products for human use. Brussels: European Commission; 2014."},{"issue":"1","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00103-022-03632-w","volume":"66","author":"C Fuhrmann","year":"2023","unstructured":"Fuhrmann C, Reineke C, Lang B, Gr\u00e4hlert X. Erste Erfahrungen bei der Umsetzung der EU-Verordnung 536\/2014 (CTR) aus Sicht der nichtkommerziellen akademischen Forschung [First experiences with the implementation of EU Regulation 536\/2014 (CTR) from the perspective of non-commercial academic research]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023;66(1):38\u201344. https:\/\/doi.org\/10.1007\/s00103-022-03632-w.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"5","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s43441-023-00553-x","volume":"57","author":"J Stans","year":"2023","unstructured":"Stans J, Verbandt S, Kromar S, Deleersnijder A. Implementation of Regulation (EU) 536\/2014 as a non-commercial sponsor: an internal survey and a descriptive analysis of timelines. Ther Innov Regul Sci. 2023;57(5):1113\u201320. https:\/\/doi.org\/10.1007\/s43441-023-00553-x.","journal-title":"Ther Innov Regul Sci"},{"issue":"1","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13063-023-07869-x","volume":"25","author":"TDJH Patrick-Brown","year":"2024","unstructured":"Patrick-Brown TDJH, Bourner J, Kali S, et al. Experiences and challenges with the new European Clinical Trials Regulation. Trials. 2024;25(1):3. https:\/\/doi.org\/10.1186\/s13063-023-07869-x. Published 2024 Jan 2.","journal-title":"Trials"},{"key":"1059_CR16","volume-title":"Espa\u00f1a vuelve a liderar los ensayos cl\u00ednicos en Europa, pero afronta el reto de competir en la carrera biom\u00e9dica global. Informe sectorial","author":"Farmaindustria","year":"2025","unstructured":"Farmaindustria. Espa\u00f1a vuelve a liderar los ensayos cl\u00ednicos en Europa, pero afronta el reto de competir en la carrera biom\u00e9dica global. Informe sectorial. Madrid: Farmaindustria; 2025."},{"key":"1059_CR17","volume-title":"Finaliza el periodo de transici\u00f3n de los ensayos cl\u00ednicos con medicamentos al nuevo sistema europeo","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS)","year":"2025","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Finaliza el periodo de transici\u00f3n de los ensayos cl\u00ednicos con medicamentos al nuevo sistema europeo. Madrid: AEMPS; 2025."}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01059-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:37:07Z","timestamp":1791297427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-01059-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":17,"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01059-y","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not required.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}